Annotation Detail for ADSSL1
Basic Information
Top
Pathway ID | Pathway Name |
---|
PWY-841 | purine nucleotides de novo biosynthesis II |
Pathway ID | Pathway Name |
---|
hsa00250 | Alanine, aspartate and glutamate metabolism |
hsa00230 | Purine metabolism |
hsa01100 | Metabolic pathways |
Pathway ID | Pathway Name |
---|
| Metabolism of nucleotides |
Pathway ID | Pathway Name |
---|
P02738 | De novo purine biosynthesis |
P00057 | Wnt signaling pathway |
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of ADSSL1 mRNA | affects expression | 17562736
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of ADSSL1 mRNA | decreases expression | 20106945
|
D010634 |
Phenobarbital |
NR1I3 protein affects the reaction [Phenobarbital results in increased expression of ADSSL1 mRNA] | affects reaction|increases expression | 19482888
|
D010634 |
Phenobarbital |
Phenobarbital results in increased expression of ADSSL1 mRNA | increases expression | 19270015 19482888
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Phenobarbital |
4.18 | 6195326 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Phenobarbital |
4.71 | 17620307 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
4.71 | 10982225 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.39 | 18445737 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
3.03 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Phenobarbital |
3.03 | 20007298 20935162 17173139 1701930 6705139 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
2.81 | 10977129 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
2.82 | 12371664 |
MESH:D002493 |
Central Nervous System Diseases |
|
Phenobarbital |
4.90 | 4080065 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
3.24 | 19486331 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
1.68 | 18713872 12153990 19416960 12540782 11739529 19420014 12705907 14550746 10915739 10774834 15968718 10663392 14725611 12392966 11461765 11529661 18071297 15619225 16781746 2444490 19739265 19370779 11287661 12958197 17906064 19923254 16177239 11834606 19085960 17562736 11743745 16109766 16485898 17522070 16081117 16393943 11421492 12594235 19164858 16227642 14986274 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
4.96 | 19426721 |
MESH:D004421 |
Dystonia |
|
Phenobarbital |
4.53 | 1851702 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Phenobarbital |
4.76 | 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Phenobarbital |
4.74 | 11558140 3922381 |
MESH:D004827 |
Epilepsy |
|
Phenobarbital |
3.08 | 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Phenobarbital |
3.96 | 6401628 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Phenobarbital |
4.90 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Phenobarbital |
4.76 | 3659116 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
3.34 | 19224547 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
3.79 | 12639820 12168785 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
4.54 | 16983495 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.96 | 8708960 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
5.16 | 15720958 |
MESH:D006529 |
Hepatomegaly |
|
Phenobarbital |
4.13 | 16109766 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
3.06 | 16870215 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
2.23 | 10903974 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
5.31 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
6.55 | 15629191 12587719 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
6.55 | 10903974 8314463 18776723 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
3.12 | 12371664 |
MESH:D008103 |
Liver Cirrhosis |
|
Phenobarbital |
3.10 | 21047994 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
4.22 | 11587558 16611625 19014921 12969438 19784758 19460945 12587719 16610002 |
MESH:D008107 |
Liver Diseases |
|
Phenobarbital |
4.22 | 19363144 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.68 | 17185352 16871587 |
MESH:D008113 |
Liver Neoplasms |
|
Phenobarbital |
2.43 | 19073162 19482888 15975961 21047994 8742319 19812893 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Phenobarbital |
2.95 | 1399818 6150874 17172636 2563599 18308698 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
4.22 | 19513568 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.65 | 16801185 |
MESH:D020191 |
Myoclonic Epilepsies, Progressive |
|
Phenobarbital |
5.22 | 17484760 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
5.31 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.70 | 19348381 18481113 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
3.26 | 18514411 |
MESH:D010018 |
Osteomalacia |
|
Phenobarbital |
5.11 | 17016548 |
MESH:D010146 |
Pain |
|
Acetaminophen |
2.77 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Phenobarbital |
2.61 | 16965848 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
10.38 | 12371664 |
MESH:D011230 |
Precancerous Conditions |
|
Phenobarbital |
10.38 | 2563599 |
MESH:D019310 |
Pseudolymphoma |
|
Phenobarbital |
5.36 | 12752131 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.34 | 16882103 |
MESH:D012640 |
Seizures |
|
Phenobarbital |
2.97 | 16876388 4039156 3137016 11442880 |
MESH:D003294 |
Seizures, Febrile |
|
Phenobarbital |
5.56 | 6407741 |
MESH:D013964 |
Thyroid Neoplasms |
|
Phenobarbital |
3.39 | 1399818 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
3.50 | 10982225 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.85 | 1336536 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
5.31 | 17120751 |
Drugbank ID |
Action |
Drug Name |
Description |
---|
DB00128 |
- |
L-Aspartic Acid |
Dietary supplement;Micronutrient;Non-Essential Amino Acids |
DB02109 |
- |
Hadacidin |
Antibiotics, Antineoplastic;Teratogens |
DB03510 |
- |
6-O-Phosphoryl Inosine Monophosphate |
|
DB04137 |
- |
Guanosine-5'-Triphosphate |
|
DB04184 |
- |
Acetate Ion |
Indicators and Reagents |
DB04315 |
- |
Guanosine-5'-Diphosphate |
|
DB04418 |
- |
Adenylosuccinic Acid |
|
DB04566 |
- |
Inosinic Acid |
|